Drug Profile
AD 9161
Alternative Names: AD-9161Latest Information Update: 14 Jun 2000
Price :
$50
*
At a glance
- Originator Dainippon Pharmaceutical
- Class Antiulcers; Gastric antisecretories
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 14 Jun 2000 Discontinued-Preclinical for Peptic ulcer in Japan (Unknown route)
- 16 Mar 1998 Preclinical development for Peptic ulcer in Japan (Unknown route)